by Proxiva Peptides | Mar 29, 2026 | Growth Hormone, Research Guides
Research into Ipamorelin represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 5 amino acids compound has shown promise in areas ranging from no prolactin increase to selective GH release, making it a subject of...
by Proxiva Peptides | Mar 29, 2026 | Growth Hormone, Peptide Research
The scientific community’s interest in CJC-1295 (CJC-1295 (with DAC)) has grown steadily over the past decade. Composed of 30 amino acids + DAC, this peptide has demonstrated notable effects in preclinical models related to growth hormone releasing and GHRH...
by Proxiva Peptides | Mar 7, 2026 | Growth Hormone, Peptide Research
Introduction: Peptide vs Non-Peptide Growth Hormone Secretagogues The comparison between CJC-1295 and MK-677 (ibutamoren) represents one of the most fundamental questions in growth hormone research: should GH secretion be stimulated through a peptide GHRH analog or an...
by Proxiva Peptides | Mar 7, 2026 | Growth Hormone, Peptide Research
Introduction: The First-Generation Ghrelin Mimetics Growth hormone-releasing peptides (GHRPs) represent a class of synthetic compounds that stimulate growth hormone (GH) release through the ghrelin receptor (GHS-R1a). GHRP-2 and GHRP-6 are the two most widely studied...
by Proxiva Peptides | Mar 7, 2026 | Growth Hormone, Peptide Research
Introduction: Upstream Stimulation vs Downstream Activation The growth hormone (GH) and insulin-like growth factor (IGF) axis represents one of the most extensively studied endocrine systems in biomedical research. This axis operates as a cascade: the hypothalamus...
by Proxiva Peptides | Mar 7, 2026 | Growth Hormone, Peptide Research
Introduction: Two Routes to Growth Hormone Stimulation Growth hormone (GH) research has long relied on compounds that stimulate the body’s natural GH production rather than administering exogenous GH directly. Among these, tesamorelin and MK-677 (ibutamoren)...
